PLCH2: A Potential Drug Target and Biomarker (G9651)

Target Name: PLCH2

NCBI ID: G9651

PLCH2

PLCH2: A Potential Drug Target and Biomarker

Phospholipase C-like protein 4 (PLCH2) is a protein that is expressed in various cell types, including neurons, heart muscle, and liver cells. It is a member of the phospholipase C family, which is involved in the breaking down of phospholipid molecules that form the cell membrane. PLCH2 has been shown to play a role in a variety of cellular processes, including cell signaling, inflammation, and stress response. As a result, PLCH2 has potential as a drug target and biomarker.

One of the key functions of PLCH2 is its role in cell signaling. PLCH2 has been shown to be involved in the regulation of several signaling pathways, including the insulin/IGF-1 signaling pathway and the neurotransmitter signaling pathway. These signaling pathways are important for a variety of cellular processes, including metabolism, growth, and survival. By interacting with other proteins and molecules, PLCH2 helps to regulate these signaling pathways and maintain cellular homeostasis.

Another function of PLCH2 is its role in inflammation. PLCH2 has been shown to be involved in the regulation of inflammation response. When the body is exposed to an infection or injury, PLCH2 helps to coordinate the immune response by breaking down the phospholipid molecules that form the cell membrane and allowing immune cells to gain access to the site of injury or infection. This process is important for promoting an effective immune response and for limiting tissue damage.

In addition to its role in cell signaling and inflammation, PLCH2 has also been shown to be involved in stress response. PLCH2 has been shown to play a role in the regulation of cellular stress responses, including the production of reactive oxygen species (ROS) and the activation of cellular signaling pathways that are involved in stress response. This process is important for maintaining cellular homeostasis and for promoting cellular survival in response to stress.

As a result of its involvement in these processes, PLCH2 has potential as a drug target and biomarker. For example, if a drug can be developed that targets PLCH2, it may be able to interfere with its function as a signaling protein and/or an immune and stress response protein. This could potentially lead to a variety of therapeutic benefits, including the treatment of various diseases and disorders. In addition, if PLCH2 can be used as a biomarker for certain diseases, it may be able to provide valuable information about the severity and progression of these diseases.

In conclusion, PLCH2 is a protein that is involved in a variety of cellular processes, including cell signaling, inflammation, and stress response. As a result, PLCH2 has potential as a drug target and biomarker. Further research is needed to fully understand the functions of PLCH2 and to develop drugs that can target its activity. If successful, these drugs may be able to provide valuable therapeutic benefits for a variety of diseases and disorders.

Protein Name: Phospholipase C Eta 2

Functions: The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes (PubMed:18361507). This phospholipase activity is very sensitive to calcium. May be important for formation and maintenance of the neuronal network in the postnatal brain (By similarity)

The "PLCH2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLCH2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets